StonvexLoading…
StonvexStonvexStonvexCore line items from MYSE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $73.00 | $550.00 | $489.00 | $161.00 |
Operating Income | $-1.69M | $-5.49M | $-4.35M | $-3.07M |
Net Income | $-2.86M | $-2.61M | $-3.89M | $-2.69M |
EPS (Diluted) | $-0.67 | $-0.62 | $-0.93 | $-0.65 |
Total Assets | $4.95M | $7.20M | $6.76M | $7.45M |
Total Liabilities | $1.08M | $1.09M | $1.07M | $838.99K |
Cash & Equivalents | $777.16K | $749.03K | $457.63K | $407.89K |
Free Cash Flow OCF − CapEx | Not available | $-4.27M | $-3.52M | $-2.62M |
Shares Outstanding | 4.32M | 4.26M | 4.26M | 4.21M |